untitled
<OAI-PMH schemaLocation=http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd>
<responseDate>2018-01-15T18:21:19Z</responseDate>
<request identifier=oai:HAL:hal-01332030v1 verb=GetRecord metadataPrefix=oai_dc>http://api.archives-ouvertes.fr/oai/hal/</request>
<GetRecord>
<record>
<header>
<identifier>oai:HAL:hal-01332030v1</identifier>
<datestamp>2017-12-21</datestamp>
<setSpec>type:ART</setSpec>
<setSpec>subject:sdv</setSpec>
<setSpec>collection:UNIV-AG</setSpec>
<setSpec>collection:INRA</setSpec>
<setSpec>collection:UNAM</setSpec>
<setSpec>collection:IRSET</setSpec>
<setSpec>collection:UNIV-NANTES</setSpec>
<setSpec>collection:UNIV-RENNES1</setSpec>
<setSpec>collection:IRSET-PPB</setSpec>
<setSpec>collection:IFR140</setSpec>
<setSpec>collection:BIOSIT</setSpec>
<setSpec>collection:EHESP</setSpec>
<setSpec>collection:INSERM</setSpec>
<setSpec>collection:UR1-HAL</setSpec>
<setSpec>collection:UR1-UFR-SVE</setSpec>
<setSpec>collection:USPC</setSpec>
<setSpec>collection:UR1-SDV</setSpec>
<setSpec>collection:UNIV-ANGERS</setSpec>
<setSpec>collection:AGREENIUM</setSpec>
<setSpec>collection:IRSET-PROTIM</setSpec>
</header>
<metadata><dc>
<publisher>HAL CCSD</publisher>
<title lang=en>Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.</title>
<creator>Lardenois, Aurélie</creator>
<creator>Jagot, Sabrina</creator>
<creator>Lagarrigue, Mélanie</creator>
<creator>Guével, Blandine</creator>
<creator>Ledevin, Mireille</creator>
<creator>Larcher, Thibaut</creator>
<creator>Dubreil, Laurence</creator>
<creator>Pineau, Charles</creator>
<creator>Rouger, Karl</creator>
<creator>Guével, Laétitia</creator>
<contributor>INRA Nantes (BIA) ; Institut National de la Recherche Agronomique (INRA)</contributor>
<contributor>Ecole Nationale Vétérinaire, Agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS)</contributor>
<contributor>Université de Nantes (UN)</contributor>
<contributor>Institut de recherche, santé, environnement et travail [Rennes] (Irset) ; Université d'Angers (UA) - Université des Antilles et de la Guyane (UAG) - Université de Rennes 1 (UR1) - École des Hautes Études en Santé Publique [EHESP] (EHESP) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )</contributor>
<contributor>Université de Rennes 1 (UR1)</contributor>
<contributor>Plateforme Protéomique-Biogenouest (PPB) ; Institut de recherche, santé, environnement et travail [Rennes] (Irset) ; Université d'Angers (UA) - Université des Antilles et de la Guyane (UAG) - Université de Rennes 1 (UR1) - École des Hautes Études en Santé Publique [EHESP] (EHESP) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ) - Université d'Angers (UA) - Université des Antilles et de la Guyane (UAG) - Université de Rennes 1 (UR1) - École des Hautes Études en Santé Publique [EHESP] (EHESP) - Institut National de la Santé et de la Recherche Médicale (INSERM) - Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ) - Proteomics Core Facility (Protim) ; Université de Rennes 1 (UR1) - Plateforme Génomique Santé Biogenouest® - Plateforme Génomique Santé Biogenouest®</contributor>
<contributor>Association Française contre les Myopathies. Grant Number: AFM N 14379, FEDER (Fonds Européens de Développement Régional). Grant Number: N 37085</contributor>
<description>International audience</description>
<source>ISSN: 1615-9853</source>
<source>EISSN: 1615-9861</source>
<source>Proteomics</source>
<publisher>Wiley-VCH Verlag</publisher>
<identifier>hal-01332030</identifier>
<identifier>https://hal.archives-ouvertes.fr/hal-01332030</identifier>
<identifier>https://hal.archives-ouvertes.fr/hal-01332030/document</identifier>
<identifier>https://hal.archives-ouvertes.fr/hal-01332030/file/Quantitative%20proteome%20profiling%20of%20dystrophic%20dog%20skeletal%20muscle_accepted.pdf</identifier>
<source>https://hal.archives-ouvertes.fr/hal-01332030</source>
<source>Proteomics, Wiley-VCH Verlag, 2016, 16 (14), pp.2028-2042. 〈10.1002/pmic.201600002〉</source>
<identifier>DOI : 10.1002/pmic.201600002</identifier>
<relation>info:eu-repo/semantics/altIdentifier/doi/10.1002/pmic.201600002</relation>
<identifier>PRODINRA : 356589</identifier>
<identifier>PUBMED : 27246553</identifier>
<relation>info:eu-repo/semantics/altIdentifier/pmid/27246553</relation>
<language>en</language>
<subject lang=en>Muscle stem cell</subject>
<subject lang=en>Cell therapy</subject>
<subject lang=en>Duchenne Muscular Dystrophy</subject>
<subject lang=en>GRMD dog model</subject>
<subject lang=en> ICPL</subject>
<subject>[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology</subject>
<type>info:eu-repo/semantics/article</type>
<type>Journal articles</type>
<description lang=en>Proteomic profiling plays a decisive role in the elucidation of molecular signatures representative of a specific clinical context. MuStem cell-based therapy represents a promising approach for clinical applications to cure Duchenne Muscular Dystrophy (DMD). To expand our previous studies collected in the clinically relevant DMD animal model, we decided to investigate the skeletal muscle proteome four months after systemic delivery of allogenic MuStem cells. Quantitative proteomics with isotope-coded protein labelling (ICPL) was used to compile quantitative changes in the protein expression profiles of muscle in transplanted Golden Retriever Muscular Dystrophy (GRMD) dogs as compared to GRMD dogs. A total of 492 proteins were quantified, including 25 that were overrepresented and 46 that were underrepresented after MuStem cell transplantation. Interestingly, this study demonstrates that somatic stem cell therapy impacts on the structural integrity of the muscle fascicle by acting on fibres and its connections with the extracellular matrix. We also show that cell infusion promotes protective mechanisms against oxidative stress and favours the initial phase of muscle repair. This study allows us to identify putative candidates for tissue markers that might be of great value in objectively exploring the clinical benefits resulting from our cell-based therapy for DMD. </description>
<date>2016-07-14</date>
<rights>info:eu-repo/semantics/OpenAccess</rights>
</dc>
</metadata>
</record>
</GetRecord>
</OAI-PMH>
